Centese Stock

Develops cardiothoracic post-operative medical equipment for post-operative surgical care and patient monitoring.

Sign up today and learn more about Centese Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Centese Stock

Centese is a medical device company that develops Thoraguard, a reliable surgical drainage system. Using digital intelligence, Thoraguard revolutionizes operative drainage in cardiothoracic surgery. Thoraguard is a digital technology that provides accurate data monitoring and automatic chest tube clearing with the goal of enhancing clinical judgment and patient safety. Centese is committed to delivering improved post-operative surgical drainage solutions that are designed for safety, intelligence, and effectiveness in order to enhance results and save costs in cardiothoracic surgery.

Funding History

December 2015$180K
March 2017$1.4M
November 2017$2.9M
August 2019$2.0M
November 2023$15.0M


Board Member

Mr. Still

Co-Founder and CEO

Evan Luxon


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: